Thrombosis and Antiphospholipid Syndrome: A Preliminary Assessment of Three Antithrombotic Treatments

Lupus

Volumn 3, Issue 2, 1994, Pages 85-90

  Rivier, Gilles ^a   Herranz, M Teresa ^a   Khamashta, Munther A ^a   Hughes, Graham R v ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Anticardiolipin; Anticoagulants; Lupus

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; WARFARIN;

ADOLESCENT; ADULT; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ADOLESCENT; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; THROMBOSIS; WARFARIN;

EID: 0028304089     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/096120339400300205     Document Type: Article

References (57)

1. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-4.
2. Harris EN, Baguley E., Asherson RA, Hughes GRV. Clinical and serological features of the antiphospholipid syndrome (APS). Br J Rheumatol 1987; 26(Suppl. 2): 19 (abstract).
3. Asherson RA, Khamashta MA, Ordi-Ros J. et al. The 'primary' antiphospholipid syndrome: major clinical and serological features. Medicine 1989; 89: 366-74.
4. Asherson RA A 'primary' antiphospholipid syndrome? J Rheumatol 1988; 15: 1742-6.
5. Mackworth-Young CG, Loizou S., Walport MJ Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis 1989; 48: 362-7.
6. Love PE, Santoro SA Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance. Ann Intern Med 1990; 112: 682-98.
7. Alarcon-Segovia D., Delezé M., Oria CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989; 68: 353-65.
8. Asherson RA, Khamashta MA, Gil A. et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease and the primary antiphospholipid syndrome. Am. J. Med 1989; 86: 391-9.
9. Briley DP, Coull BM, Goodnight SH Neurological disease associated with antiphospholipid antibodies. Ann Neurol 1989; 25: 221-7.
10. Levine SR, Brey RL, Joseph CLM, Havstad S., APASS Group. Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. Stroke 1992; 23(Suppl. I): I-29-I-32.
11. Levine SR, Syhnggwon K., Deegan MJ, Welch KMA. Ischemic stroke associated with anticardiolipin antibodies. Stroke 1987; 18: 1101-6.
12. Levine RL, Deegan MJ, Futrell N., Welch KMA. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990; 40: 1181-9.
13. Ford PM, Brunet D., Lillicarp DP, Ford SE Premature stroke in a family with lupus anticoagulatn and antiphospholipid antibodies. Stroke 1990; 21: 66-71.
14. The APASS Group. Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke 1990; 21: 1268-73.
15. Kushner MJ Prospective study of anticardiolipin antibodies in stroke. Stroke 1990; 21: 295-8.
16. Coull BM, Goodnight SH Antiphospholipid antibodies, prethrombotic states and stroke. Stroke 1990; 25: 13-18.
17. Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GRV. Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 1984; 2: 47-51.
18. Montalban J., Codina A., Ordi J. et al. Antiphospholipid antibodies in cerebral ischemia. Stroke 1991; 22: 750-3.
19. Williams RC Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 1984; 2: 3-4.
20. Piette JC, Wechsler B., Blétry O., Frances C. Approche clinique du syndrome des antiphospholipides: des faits aux interrogations. La Presse Médicale 1992; 21: 2081-4.
21. Lockshin MD Which patients with antiphospholipid antibody should be treated and how? Rheum Dis North Am 1993; 19: 235-47.
22. Khamashta MA, Wallington T. Management of the antiphospholipid syndrome. Ann Rheum Dis 1991; 50: 959-62.
23. Babikian VL, Levine SR Therapeutic considerations for stroke patients with antiphospholipid antibodies. Stroke 1992; 23(Suppl. I): I-33-I-37.
24. Exner T., Rickard KA, Kronenberg H. Studies on phospholipids in the action of a lupus coagulation inhibitor. Pathology 1975; 7: 319-28.
25. Gharavi AE, Harris EN, Asherson RA et al. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1-6.
26. Harris EN, Gharavi AE, Patel SP et al. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 2115-22.
27. Whisnant JP Special report from the National Institute of Neurologic Disorder and Stroke. Classification of cerebrovascular diseases. III. Stroke 1990; 21: 637-76.
28. McNeil HP, Chesterman CN, Krilis SA Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49: 193-279.
29. Alarcon-Segovia D., Perez-Vazquez ME, Villa AR, Drenkard C., Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992; 21: 275-86.
30. Kittner SJ, Gorelick PB Antiphospholipid antibodies and stroke: an epidemiologic perspective. Stroke 1992; 23(Suppl. I): I-19-I-22.
31. Hess DC Stroke associated with antiphospholipid antibodies. Stroke 1992; 23(Suppl. I): I-23-I-28.
32. Brey RL, Hart RG, Sherman DG, Tegeler CH Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990; 40: 1190-6.
33. Levine SR, Welch KMA. The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulatns and anticardiolipin antibodies. Arch Neurol 1987; 44: 876-83.
34. Ginsburg KS, Liang MH, Newcomer L. et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992; 117: 997-1002.
35. Bakimner R., Fishman P., Blank M. et al. Induction of antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992; 89: 1558-63.
36. Hughes GRV, Harris EN, Gharavi AE The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-9.
37. Ingram SB, Goodnight SH, Benett RM An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two cases. Arthritis Rheum 1987; 30: 1167-72.
38. Smith KJ, Skelton HG, James WD et al. Cutaneous histopathologic findings in 'antiphospholipid syndrome'. Correlation with disease, including human immunodeficiency virus disease. Arch Dermatol 1990; 126: 1176-83.
39. Reyes E., Alarcon-Segovia D. Leg ulcers in the primary antiphaspholipid syndrome. Report of a case with a peculiar proliferative small vessel vasculopathy. Clin Exp Rheumatol 1991; 9: 63-66.
40. Bowles CA Vasculopathy associated with the antiphospholipid antibody syndrome. Rheum Dis North Am 1990; 16: 471-89.
41. Lie JT Vasculopathy in the antiphospholipid syndrome: thrombosis or vasculitis, or both? J Rheumatol 1989; 16: 713-15.
42. Harris EN An acute disseminated coagulopathy-vasculapathy associated with the antiphospholipid syndrome. Arch Intern Med 1991; 151: 231-3.
43. Asherson RA Thge catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 508-12.
44. Barbut D., Borer JS, Wallerson D. et al. Anticardiolipin antibody and stroke: possible relation of valvular heart disease and embolic events. Cardiology 1991; 79: 99-109.
45. Nardone Soscia P, Romain PL Antiphospholipid antibodies: is there a role in cardiac valvular disease and its thromboembolic complications? Cardiology 1992; 80: 1-6.
46. Eber B. Anticardiolipin antibody and stroke: possible relation of valvular heart disease and embolic events. Cardiology 1992; 80: 156.
47. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117: 303-8.
48. Landi G., Calloni MV, Sabbadini MG et al. Recurrent ischemic attacks in two young adults with lupus anticoagulant. Stroke 1983; 14: 377-9.
49. Fischer M., McGehee W. Cerebral infarct, TIA and lupus inhibitor. Neurology 1986; 36: 1234-7.
50. Young SM, Fischer M., Sigsbee A., Erichetti A. Cardiogenic brain embolism and lupus anticoagulant. Ann Neurol 1989; 26: 390-2.
51. Pope JM, Canny CLB, Bell DA Cerebral ischemic events associated with endocarditis, retinal vascular disease and lupus anticoagulant. Am J Med 1991; 90: 299-309.
52. Asherson RA, Baguley E., Pal C., Hughes GRV. Antiphospholipid syndrome: five year follow-up. Ann Rheum Dis 1991; 50: 805-10.
53. Asherson RA, Chan JKH, Harris EN et al. Anticardiolipin antibody, recurrent thrombosis and warfarin withdrawal. Ann Rheum Dis 1985; 44: 823-5.
54. Derksen RHWM, de Groot PG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long-term anticoagulant treatment. Ann Rheum Dis 1993; 52: 689-92.
55. Hirsh J. Oral anticoagulant drugs. New Engl J Med 1991; 324: 1865-75.
56. Hull R., Hirsh J., Jay R. et al. Different intensities of oral anticoagulant therapy in the treatment of proximal vein thrombosis. New Engl J Med 1982; 307: 1676-81.
57. Gerstmann BB, Piper JM, Tomita DK et al. Oral contraceptive estrogen dose and the risk of deep vein thromboembolic disease. Am J Epidemiol 1991; 133: 32-7.